1. Early brain damage in essential hypertension: “To have and have not”—Is it important?

   • Cristina Sierra

   Invited Commentary Pages: 269 - 270

2. Web Alert

   • Adam Weinstein

   News Pages: 271 - 272

3. Clinical trials report

   • Helmy M. Siragy

   BriefCommunication Pages: 275 - 276

4. Clinical trials report

   • Michael A. Weber

   BriefCommunication Pages: 277 - 278

5. The latest generation of beta-blockers: New pharmacologic properties

   • Michala E. Pedersen
   • John R. Cockcroft

   OriginalPaper Pages: 279 - 286

6. Monitoring vascular health beyond blood pressure

   • Daniel A. Duprez
   • Jay N. Cohn

   OriginalPaper Pages: 287 - 291

7. Role of diet in hypertension management

   • Kevin M. O’Shaughnessy

   OriginalPaper Pages: 292 - 297

8. Endothelin, the kidney, and hypertension

   • Joey P. Granger
   • Sean Abram
   • Babbette LaMarca

   OriginalPaper Pages: 298 - 303

9. Clinical trials report

   • Dan Carl
   • Domenic A. Sica

   BriefCommunication Pages: 307 - 308

10. Genetic information in the diagnosis and treatment of hypertension

    • Maciej Tomaszewski
    • Lukas Zimmerli
    • Anna F. Dominiczak

    OriginalPaper Pages: 309 - 316

11. Secondary prevention of stroke by blood pressure-lowering treatment

    • Hisatomi Arima
    • John Chalmers

    OriginalPaper Pages: 317 - 323

12. Moving beyond guidelines: Are report cards the answer to high rates of uncontrolled hypertension?

    • Marcel Ruzicka
    • Frans H. H. Leenen

    OriginalPaper Pages: 324 - 329

13. Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring

    • Giuseppe Mancia
    • Gianfranco Parati

    OriginalPaper Pages: 330 - 337

14. Alcohol and its relationship to blood pressure

    • Lavanya Kodavali
    • Raymond R. Townsend

    OriginalPaper Pages: 338 - 344

15. Phosphodiesterase-5 inhibitors and their hemodynamic effects

    • L. Michael Prisant

    OriginalPaper Pages: 345 - 351